Breaking News Instant updates and real-time market news.

WMT

Walmart

$119.37 /

+0.74 (+0.62%)

16:57
04/03/20
04/03
16:57
04/03/20
16:57

Walmart to start limiting number of customers in store at one time

Walmart said that, starting Saturday, it will limit the number of customers who can be in a store at once. Stores will now allow no more than five customers for each 1000 square feet at a given time, roughly 20 percent of a store's capacity. To manage this restriction, the associates at a store will mark a queue at a single-entry door (in most cases the Grocery entrance) and direct arriving customers there, where they will be admitted one-by-one and counted. Associates and signage will remind customers of the importance of social distancing while they're waiting to enter a store - especially before it opens in the morning. Once a store reaches its capacity, customers will be admitted inside on a "1-out-1-in" basis. "We'll also institute one-way movement through our aisles next week in a number of our stores, using floor markers and direction from associates," the company said. "We expect this to help more customers avoid coming into close contact with others as they shop. We'll continue to put signage inside our stores to remind customers of the need to maintain social distancing - especially in lines. And once customers check out, they will be directed to exit through a different door than they entered, which should help lessen the instances of people closely passing each other."

  • 19

    May

  • 14

    Sep

WMT Walmart
$119.37 /

+0.74 (+0.62%)

03/31/20
Fly Intel: Top five analyst initiations
03/31/20 Wolfe Research
Walmart initiated with an Outperform at Wolfe Research
03/26/20
Fly Intel: Top five analyst initiations
03/26/20 Atlantic Equities
Walmart initiated with an Overweight at Atlantic Equities

TODAY'S FREE FLY STORIES

Hot Stocks
China Customer Relations Centers: Going private proposal withdrawn » 07:32
05/29/20
05/29
07:32
05/29/20
07:32
CCRC

China Customer Relations Centers

$4.50 /

-0.01 (-0.22%)

China Customer Relations…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Abercrombie & Fitch price target raised to $13 from $11 at RBC Capital » 07:31
05/29/20
05/29
07:31
05/29/20
07:31
ANF

Abercrombie & Fitch

$11.59 /

-1.49 (-11.39%)

RBC Capital analyst Kate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANF Abercrombie & Fitch
$11.59 /

-1.49 (-11.39%)

ANF Abercrombie & Fitch
$11.59 /

-1.49 (-11.39%)

04/03/20
Fly Intel: Top five analyst upgrades
04/03/20 B. Riley FBR
B. Riley FBR upgrades Abercrombie on ability to 'weather the storm'
04/03/20 B. Riley FBR
Abercrombie & Fitch upgraded to Buy from Neutral at B. Riley FBR
03/24/20 Wedbush
Microsoft, Alphabet among stocks in Wedbush's Shopping List
ANF Abercrombie & Fitch
$11.59 /

-1.49 (-11.39%)

ANF Abercrombie & Fitch
$11.59 /

-1.49 (-11.39%)

ANF Abercrombie & Fitch
$11.59 /

-1.49 (-11.39%)

ANF Abercrombie & Fitch
$11.59 /

-1.49 (-11.39%)

Periodicals
Latam Airlines U.S. bankruptcy filing to delay bailout until July, Reuters says » 07:28
05/29/20
05/29
07:28
05/29/20
07:28
LTM

Latam Airlines

$1.12 /

-0.13 (-10.44%)

, AZUL

Azul

$8.14 /

-0.26 (-3.10%)

, GOL

Gol Linhas

$4.50 /

-0.2 (-4.26%)

Latam Airlines'…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LTM Latam Airlines
$1.12 /

-0.13 (-10.44%)

AZUL Azul
$8.14 /

-0.26 (-3.10%)

GOL Gol Linhas
$4.50 /

-0.2 (-4.26%)

LTM Latam Airlines
$1.12 /

-0.13 (-10.44%)

05/28/20 BofA
Latam Airlines reinstated with an Underperform at BofA
05/27/20 Deutsche Bank
Latam Airlines downgraded to Sell from Hold at Deutsche Bank
05/26/20 Raymond James
Latam Airlines downgraded to Underperform from Outperform at Raymond James
05/04/20 Deutsche Bank
Avianca downgraded to Sell from 50c price target at Deutsche Bank
AZUL Azul
$8.14 /

-0.26 (-3.10%)

05/28/20 BofA
Azul reinstated with a Neutral at BofA
05/04/20 Deutsche Bank
Avianca downgraded to Sell from 50c price target at Deutsche Bank
04/24/20 Morgan Stanley
Azul downgraded to Equal Weight from Overweight at Morgan Stanley
03/17/20 Deutsche Bank
Azul downgraded to Hold from Buy at Deutsche Bank
GOL Gol Linhas
$4.50 /

-0.2 (-4.26%)

05/28/20 BofA
Gol Linhas reinstated with a Neutral at BofA
04/24/20 Morgan Stanley
Gol Linhas downgraded to Equal Weight from Overweight at Morgan Stanley
04/08/20 Goldman Sachs
Gol Linhas downgraded to Neutral from Buy at Goldman Sachs
03/17/20 Deutsche Bank
Gol Linhas downgraded to Hold from Buy at Deutsche Bank
GOL Gol Linhas
$4.50 /

-0.2 (-4.26%)

LTM Latam Airlines
$1.12 /

-0.13 (-10.44%)

AZUL Azul
$8.14 /

-0.26 (-3.10%)

LTM Latam Airlines
$1.12 /

-0.13 (-10.44%)

LTM Latam Airlines
$1.12 /

-0.13 (-10.44%)

Recommendations
Ulta Beauty price target raised to $270 from $240 at Oppenheimer » 07:27
05/29/20
05/29
07:27
05/29/20
07:27
ULTA

Ulta Beauty

$243.36 /

-8.48 (-3.37%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

06:29 Today Wells Fargo
Ulta Beauty price target raised to $300 from $250 at Wells Fargo
05/12/20 Cleveland Research
Ulta Beauty lost share to Target and Sephoria, says Cleveland Research
05/11/20 Nomura Instinet
Ulta Beauty price target raised to $220 from $190 at Nomura Instinet
05/01/20 JPMorgan
Ulta Beauty, BJ's best near-term picks in retail, says JPMorgan
ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

Recommendations
Okta price target raised to $185 from $130 at Oppenheimer » 07:26
05/29/20
05/29
07:26
05/29/20
07:26
OKTA

Okta

$183.99 /

+4.48 (+2.50%)

Oppenheimer analyst Shaul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$183.99 /

+4.48 (+2.50%)

OKTA Okta
$183.99 /

+4.48 (+2.50%)

06:45 Today Mizuho
Okta price target raised to $178 from $165 at Mizuho
06:43 Today Morgan Stanley
Okta price target raised to $173 from $131 at Morgan Stanley
06:02 Today Piper Sandler
Okta price target raised to $190 from $145 at Piper Sandler
05/26/20 Cowen
Okta price target raised to $195 from $150 at Cowen
OKTA Okta
$183.99 /

+4.48 (+2.50%)

OKTA Okta
$183.99 /

+4.48 (+2.50%)

OKTA Okta
$183.99 /

+4.48 (+2.50%)

OKTA Okta
$183.99 /

+4.48 (+2.50%)

Downgrade
Trimble downgraded to Hold from Buy at Craig-Hallum » 07:25
05/29/20
05/29
07:25
05/29/20
07:25
TRMB

Trimble

$41.99 /

-0.58 (-1.36%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRMB Trimble
$41.99 /

-0.58 (-1.36%)

TRMB Trimble
$41.99 /

-0.58 (-1.36%)

07:21 Today Craig-Hallum
Trimble downgraded to Hold from Buy at Craig-Hallum
03/24/20 Needham
Trimble price target lowered to $34 from $48 at Needham
01/09/20 KeyBanc
Trimble initiated with a Sector Weight at KeyBanc
07/10/19 JPMorgan
Trimble downgraded to Neutral from Overweight at JPMorgan
TRMB Trimble
$41.99 /

-0.58 (-1.36%)

Hot Stocks
Quest Diagnostics, Home State Health partner on COVID-19 testing » 07:25
05/29/20
05/29
07:25
05/29/20
07:25
DGX

Quest Diagnostics

$118.10 /

+2.55 (+2.21%)

Home State Health…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DGX Quest Diagnostics
$118.10 /

+2.55 (+2.21%)

DGX Quest Diagnostics
$118.10 /

+2.55 (+2.21%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
04/28/20
Fly Intel: Top five analyst upgrades
04/28/20 Morgan Stanley
Morgan Stanley upgrades Quest Diagnostics to Overweight on COVID testing boost
04/28/20 Morgan Stanley
Quest Diagnostics upgraded to Overweight from Equal Weight at Morgan Stanley
DGX Quest Diagnostics
$118.10 /

+2.55 (+2.21%)

DGX Quest Diagnostics
$118.10 /

+2.55 (+2.21%)

DGX Quest Diagnostics
$118.10 /

+2.55 (+2.21%)

Downgrade
VF Corp. downgraded to Hold from Buy at Argus » 07:23
05/29/20
05/29
07:23
05/29/20
07:23
VFC

VF Corp.

$58.84 /

-3.33 (-5.36%)

Argus analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

07:15 Today Argus
VF Corp. downgraded to Hold from Buy at Argus
05/18/20 Susquehanna
VF Corp. price target lowered to $60 from $66 at Susquehanna
05/18/20 Credit Suisse
VF Corp. price target lowered to $60 from $70 at Credit Suisse
04/28/20 BTIG
VF Corp. initiated with a Neutral at BTIG
VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

Hot Stocks
Rexford Industrial acquires industrial property for $14.5M » 07:23
05/29/20
05/29
07:23
05/29/20
07:23
REXR

Rexford Industrial

$40.09 /

+0.59 (+1.49%)

Rexford Industrial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REXR Rexford Industrial
$40.09 /

+0.59 (+1.49%)

REXR Rexford Industrial
$40.09 /

+0.59 (+1.49%)

05/04/20 Capital One
Rexford Industrial downgraded to Equalweight from Overweight at Capital One
05/04/20 Capital One
Rexford Industrial downgraded to Equalweight from Overweight at Capital One
02/12/20 Stifel
Rexford has best lease dynamics among industrial REITs, says Stifel
08/07/19 Jefferies
Jefferies goes to Overweight from Underweight on smid-cap real estate sector
REXR Rexford Industrial
$40.09 /

+0.59 (+1.49%)

Downgrade
Straumann downgraded to Underweight from Overweight at Morgan Stanley » 07:23
05/29/20
05/29
07:23
05/29/20
07:23
SAUHY

Straumann

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAUHY Straumann
$0.00 /

+ (+0.00%)

05:41 Today Morgan Stanley
Straumann downgraded to Underweight from Overweight at Morgan Stanley
05/21/20 Deutsche Bank
Straumann price target lowered to CHF 860 from CHF 890 at Deutsche Bank
05/15/20 JPMorgan
Straumann downgraded to Underweight from Neutral at JPMorgan
05/06/20 Kepler Cheuvreux
Straumann downgraded to Hold from Buy at Kepler Cheuvreux
Hot Stocks
Former Twitter CEO Dick Costolo attacks Facebook after Fox News interview » 07:23
05/29/20
05/29
07:23
05/29/20
07:23
TWTR

Twitter

$31.60 /

-1.46 (-4.42%)

, FB

Facebook

$225.14 /

-4.03 (-1.76%)

Former Twitter (TWTR) CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

FB Facebook
$225.14 /

-4.03 (-1.76%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
05/01/20
Fly Intel: Top five analyst downgrades
05/01/20 Deutsche Bank
Twitter price target raised to $28 from $22 at Deutsche Bank
FB Facebook
$225.14 /

-4.03 (-1.76%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
05/21/20 Stifel
Facebook price target raised to $260 from $245 at Stifel
05/20/20 Deutsche Bank
Facebook Shops could be $30B revenue opportunity, says Deutsche Bank
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

FB Facebook
$225.14 /

-4.03 (-1.76%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

FB Facebook
$225.14 /

-4.03 (-1.76%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

FB Facebook
$225.14 /

-4.03 (-1.76%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

FB Facebook
$225.14 /

-4.03 (-1.76%)

Downgrade
Trimble downgraded to Hold from Buy at Craig-Hallum » 07:21
05/29/20
05/29
07:21
05/29/20
07:21
TRMB

Trimble

$41.99 /

-0.58 (-1.36%)

Craig-Hallum downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRMB Trimble
$41.99 /

-0.58 (-1.36%)

TRMB Trimble
$41.99 /

-0.58 (-1.36%)

03/24/20 Needham
Trimble price target lowered to $34 from $48 at Needham
01/09/20 KeyBanc
Trimble initiated with a Sector Weight at KeyBanc
07/10/19 JPMorgan
Trimble downgraded to Neutral from Overweight at JPMorgan
TRMB Trimble
$41.99 /

-0.58 (-1.36%)

Hot Stocks
Akari Therapeutics says ongoing trials disrupted due to coronavirus spread » 07:21
05/29/20
05/29
07:21
05/29/20
07:21
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Downgrade
Continental AG downgraded to Equal Weight from Overweight at Morgan Stanley » 07:21
05/29/20
05/29
07:21
05/29/20
07:21
CTTAY

Continental AG

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTTAY Continental AG
$0.00 /

+ (+0.00%)

05/19/20 UBS
Continental AG price target raised to EUR 70 from EUR 62 at UBS
04/03/20 Pareto
Continental AG upgraded to Buy from Hold at Pareto
03/26/20 Morgan Stanley
Continental AG price target lowered to EUR 100 from EUR 120 at Morgan Stanley
03/25/20 Jefferies
Continental AG upgraded to Buy from Hold at Jefferies
Upgrade
Valeo upgraded to Overweight from Equal Weight at Morgan Stanley » 07:20
05/29/20
05/29
07:20
05/29/20
07:20
VLEEY

Valeo

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VLEEY Valeo
$0.00 /

+ (+0.00%)

05/11/20 Citi
Citi opens '90-day Negative Catalyst ' on Valeo
05/07/20 Kepler Cheuvreux
Valeo downgraded to Reduce from Hold at Kepler Cheuvreux
04/01/20 Barclays
Valeo downgraded to Equal Weight from Overweight at Barclays
03/30/20 Exane BNP Paribas
Valeo upgraded to Neutral from Underperform at Exane BNP Paribas
Hot Stocks
Canopy Growth down 14% to $18.67 after reporting Q4 results  07:20
05/29/20
05/29
07:20
05/29/20
07:20
CGC

Canopy Growth

$22.13 /

+2.26 (+11.37%)

 
ShowHide Related Items >><<
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

05/22/20 BofA
Canopy Growth resumed with a Buy at BofA
05/14/20 Cantor Fitzgerald
Canopy Growth price target lowered to C$25 from C$27 at Cantor Fitzgerald
04/16/20
Fly Intel: Top five analyst upgrades
04/16/20 Jefferies
Canopy Growth upgraded to Hold following pullback at Jefferies
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

Hot Stocks
Akari Therapeutics pursuing clinical study opportunities in COVID-19 pneumonia » 07:19
05/29/20
05/29
07:19
05/29/20
07:19
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

The Company believes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Hot Stocks
CannTrust: Health Canada says licenses for Fenwick facility reinstated » 07:18
05/29/20
05/29
07:18
05/29/20
07:18
CTST

CannTrust

$0.64 /

+ (+0.00%)

CannTrust announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTST CannTrust
$0.64 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

07/12/19
CannTrust downgraded to Sell from Neutral at Eight Capital
07/09/19 Roth Capital
CannTrust downgraded to Neutral from Buy at Roth Capital
07/08/19
CannTrust downgraded to Neutral from Buy at Eight Capital
07/08/19 BofA/Merrill
BofA double downgrades CannTrust to Underperform after Health Canada probe
CTST CannTrust
$0.64 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

Hot Stocks
Twitter 'doing nothing' on China propaganda, 'will be regulated,' Trump tweets » 07:18
05/29/20
05/29
07:18
05/29/20
07:18
TWTR

Twitter

$31.60 /

-1.46 (-4.42%)

President Donald Trump…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
05/01/20
Fly Intel: Top five analyst downgrades
05/01/20 Deutsche Bank
Twitter price target raised to $28 from $22 at Deutsche Bank
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

Hot Stocks
Akari Therapeutics expects interim update on Phase I/II trial in AKC in mid-2020 » 07:17
05/29/20
05/29
07:17
05/29/20
07:17
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

The Company completed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Hot Stocks
Aveo Pharmaceuticals DEDUCTIVE trial advances to Phase 2 portion » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
AVEO

Aveo Pharmaceuticals

$9.22 /

+0.47 (+5.37%)

, AZN

AstraZeneca

$53.50 /

+1.04 (+1.98%)

Aveo (AVEO) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

05/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $10 from $6 at H.C. Wainwright
04/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $6 from $4 at H.C. Wainwright
03/31/20 Piper Sandler
Aveo Pharmaceuticals price target lowered to $18.50 from $20 at Piper Sandler
03/18/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $4 from $1.75 at H.C. Wainwright
AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
05/04/20 Citi
Citi opens 'positive catalyst watch' on AstraZeneca
05/01/20 Guggenheim
AstraZeneca price target raised to 9,100 GBp from 8,900 GBp at Guggenheim
AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

Hot Stocks
Akari Therapeutics sees site initiations delayed for Phase III trial in HSCT-TMA » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

During Q1 2020, Akari…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Upgrade
Hella KGaA Hueck upgraded to Equal Weight from Underweight at Morgan Stanley » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
HLLGY

Hella KGaA Hueck

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLLGY Hella KGaA Hueck
$0.00 /

+ (+0.00%)

05/27/20 JPMorgan
Hella KGaA Hueck price target raised to EUR 35 from EUR 32 at JPMorgan
05/27/20 Kepler Cheuvreux
Hella KGaA Hueck downgraded to Reduce from Buy at Kepler Cheuvreux
03/26/20 Kepler Cheuvreux
Hella KGaA Hueck upgraded to Buy from Hold at Kepler Cheuvreux
03/25/20 Jefferies
Hella KGaA Hueck upgraded to Buy from Hold at Jefferies
Recommendations
Zscaler price target raised to $100 from $80 at Wedbush » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
ZS

Zscaler

$75.88 /

+1.34 (+1.80%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

06:32 Today Credit Suisse
Zscaler price target raised to $90 from $75 at Credit Suisse
06:14 Today Citi
Zscaler price target raised to $86 from $49 at Citi
06:03 Today Piper Sandler
Zscaler price target raised to $75 from $55 at Piper Sandler
05/26/20 Cowen
Zscaler price target raised to $80 from $70 at Cowen
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

Hot Stocks
Akari Therapeutics expects to meet with FDA, EMA on nomacopan for BP in Q3 » 07:15
05/29/20
05/29
07:15
05/29/20
07:15
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

In May 2020, Akari…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.